Iga Norichika, Nishi Hideyuki, Fujimoto Nobukazu, Kishimoto Takumi
Department of Surgery, Okayama Rosai Hospital, 1-10-25 Chikkomidorimachi, Minamiku, Okayama 702-8055, Japan.
Department of Surgery, Okayama Rosai Hospital, 1-10-25 Chikkomidorimachi, Minamiku, Okayama 702-8055, Japan.
Respir Investig. 2018 Mar;56(2):144-149. doi: 10.1016/j.resinv.2017.11.007. Epub 2018 Mar 1.
Few studies have focused on the management of secondary spontaneous pneumothorax (SSP) as a complication of pneumoconiosis. The aim of this study was to investigate the clinical features and therapeutic course of SSP associated with silicosis.
Between April 2005 and March 2015, 17 patients with silicosis underwent chest tube drainage for SSP in our institution. We retrospectively analyzed patient characteristics, type of treatment, clinical course, rate of recurrence, and survival time, and compared them with those of 30 patients diagnosed with chronic obstructive pulmonary disease (COPD) during the same period.
Fourteen patients with silicosis had performance status score ≥ 2 and modified Medical Research Council Grade ≥ 2; these were significantly different from those in patients with COPD (P = 0.047, P = 0.026). Patients with silicosis had a significantly longer duration of chest tube placement and hospital stay. Recurrent pneumothorax occurred in 47.1% of patients with silicosis, which was not significantly different from the proportion of patients with COPD (40.9%, P = 0.843). However, in the silicosis group, patients treated with chest tube drainage alone tended to have a higher rate of ipsilateral recurrence than those who had pleurodesis, although this was not statistically significant. The median overall survival time of patients with silicosis was 82.6 months, while that of patients with COPD was 104.1 months.
Patients with silicosis had worse physical status and respiratory functions at the time of occurrence of pneumothorax than those with COPD. Pleurodesis could be an effective treatment for SSP complicating silicosis.
很少有研究关注作为尘肺病并发症的继发性自发性气胸(SSP)的管理。本研究的目的是调查与矽肺相关的SSP的临床特征和治疗过程。
2005年4月至2015年3月期间,17例矽肺患者在我院接受了SSP胸腔闭式引流术。我们回顾性分析了患者的特征、治疗类型、临床过程、复发率和生存时间,并将其与同期诊断为慢性阻塞性肺疾病(COPD)的30例患者进行了比较。
14例矽肺患者的体能状态评分≥2且改良医学研究委员会分级≥2;这些与COPD患者有显著差异(P = 0.047,P = 0.026)。矽肺患者的胸腔闭式引流管放置时间和住院时间明显更长。47.1%的矽肺患者发生复发性气胸,这与COPD患者的比例无显著差异(40.9%,P = 0.843)。然而,在矽肺组中,单纯接受胸腔闭式引流治疗的患者同侧复发率往往高于接受胸膜固定术的患者,尽管这在统计学上无显著意义。矽肺患者的中位总生存时间为82.6个月,而COPD患者为104.1个月。
气胸发生时,矽肺患者的身体状况和呼吸功能比COPD患者更差。胸膜固定术可能是治疗矽肺合并SSP的有效方法。